Transcription Factor Activity Inference in Systemic Lupus Erythematosus

Area of Science:

• Immunology
• Genomics
• Systems Biology

Background:

• Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with varied symptoms.
• Understanding the regulatory circuits and transcription factor (TF) activities in SLE is crucial but globally lacking.
• This study aims to identify specific TFs involved in the pathogenesis of SLE.

Purpose of the Study:

• To decipher the roles of transcription factors (TFs) in Systemic Lupus Erythematosus (SLE).
• To identify regulatory mechanisms and cell-specific circuits underlying SLE heterogeneity.
• To uncover potential therapeutic targets for SLE based on TF dysregulation.

Main Methods:

• Inferred TF activities from comprehensive human transcriptomic data.
• Clustered SLE patients based on estimated TF activities.
• Analyzed differential TF activity patterns between SLE patients and healthy controls across two independent cohorts.

Main Results:

• Identified two distinct SLE patient subgroups characterized by differing neutrophil-to-lymphocyte ratios (NLR), consistent across pediatric and adult datasets.
• Discovered a robust list of 14 TFs significantly implicated in SLE dysregulation.
• Found known SLE regulators (e.g., STAT, IRF) alongside novel TFs suggesting new pathogenic pathways.

Conclusions:

• The study provides a foundational understanding of SLE regulatory mechanisms.
• Identified key regulatory factors contributing to SLE heterogeneity.
• These findings highlight potential novel therapeutic targets for SLE management.